The stock declined on seven of those occasions, or 78% of them, ranging from edging downward by 1.1% in November 2007 to falling 19.3% in February 1999. The two times it rose it posted gains of around ...
BTIG says a “considerable amount of our time is spent thinking and talking about” Fannie Mae (FNMA) and Freddie Mac (FMCC) because those ...
Jonathan Krinsky, BTIG chief market technician, joins 'Closing Bell' to discuss why he's cautious on Apple and the market ...
Opendoor Technologies Inc (OPEN) stock saw a decline, ending the day at $1.66 which represents a decrease of $-0.01 or -0.60% from the prior close of $1.67. The stock opened at $1.67 and touched a low ...
BTIG said it would be cautious on Apple's ( NASDAQ: AAPL) stock heading into January 2025. Analyst Jonathan Krinsky said the market can continue to make upside progress into the year-end and see a new ...
Lennar (LEN – Research Report) received a Hold rating and price target from BTIG analyst Carl Reichardt yesterday. The company’s shares ...
Fintel reports that on December 23, 2024, BTIG downgraded their outlook for Innovative Industrial Properties, Inc. - ...
FREYR Battery (FREY) sees a second day of gains after BTIG upgrades stock to Buy, shifting focus to solar module manufacturing over lithium-ion batteries.
BTIG Research upgraded shares of FREYR Battery (NYSE:FREY – Free Report) from a neutral rating to a buy rating in a research note released on Friday, MarketBeat reports. BTIG Research currently has $4 ...
BTIG Research initiated coverage on shares of Iris Energy (NASDAQ:IREN – Free Report) in a research note issued to investors on Friday morning, Marketbeat reports. The firm issued a buy rating and a ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.13% of ...
BTIG analyst Jeet Mukherjee initiated coverage of Arvinas (ARVN) with a Buy rating and $69 price target The company’s lead program, vepdegestrant, is a potent ER degrader for being developed for ...